These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1206 related articles for article (PubMed ID: 30153805)

  • 21. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological mechanisms of fecal microbiota transplantation in recurrent
    Soveral LF; Korczaguin GG; Schmidt PS; Nunes IS; Fernandes C; Zárate-Bladés CR
    World J Gastroenterol; 2022 Sep; 28(33):4762-4772. PubMed ID: 36156924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
    Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in IgA-targeted microbiota following fecal transplantation for recurrent
    Huus KE; Frankowski M; Pučić-Baković M; Vučković F; Lauc G; Mullish BH; Marchesi JR; Monaghan TM; Kao D; Finlay BB
    Gut Microbes; 2021; 13(1):1-12. PubMed ID: 33382360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of the gut microbiome following fecal microbiota transplantation.
    Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
    mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.
    Weingarden AR; Dosa PI; DeWinter E; Steer CJ; Shaughnessy MK; Johnson JR; Khoruts A; Sadowsky MJ
    PLoS One; 2016; 11(1):e0147210. PubMed ID: 26789728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.
    Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD
    BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational modeling of the gut microbiota reveals putative metabolic mechanisms of recurrent Clostridioides difficile infection.
    Henson MA
    PLoS Comput Biol; 2021 Feb; 17(2):e1008782. PubMed ID: 33617526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
    Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
    Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.
    Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ
    Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acids impact the microbiota, host, and
    McMillan AS; Theriot CM
    Gut Microbes; 2024; 16(1):2393766. PubMed ID: 39224076
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
    Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
    Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
    Staley C; Kaiser T; Vaughn BP; Graiziger C; Hamilton MJ; Kabage AJ; Khoruts A; Sadowsky MJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.
    Bruno G; Gagliardi A; Oliva A; Trancassini M; Macone A; Cicerone C; D'Abramo A; Iebba V; Auria S; Bonfiglio G; Zingaropoli MA; D'Ettorre G; Badiali D; Vullo V; Corazziari ES; Schippa S
    New Microbiol; 2019 Oct; 42(4):221-224. PubMed ID: 31609455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the mechanisms of faecal microbiota transplantation.
    Khoruts A; Sadowsky MJ
    Nat Rev Gastroenterol Hepatol; 2016 Sep; 13(9):508-16. PubMed ID: 27329806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.